Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Part D Donut Hole Costs Drug Manufacturers $461 Million Through First Half Of 2011

This article was originally published in The Pink Sheet Daily

Executive Summary

The pace of those taking advantage of the 50% discount on brand drugs provided by manufacturers is accelerating as the year progresses, with 899,000 beneficiaries getting the discounts through the end of June.
Advertisement

Related Content

Reimbursement News In Brief
Reimbursement News In Brief
Historically Low Rx Spending Increases Will Continue Through At Least 2015, IMS Exec Says
Historically Low Rx Spending Increases Will Continue Through At Least 2015, IMS Exec Says
Part D Cost Estimate Drops To $373 Bil. Over 10 Years
Part D Cost Estimate Drops To $373 Bil. Over 10 Years

Topics

Advertisement
UsernamePublicRestriction

Register

PS072728

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel